Skip to main content

Advertisement

SpringerLink
Log in

Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Cell-associated infectious HIV-1 viral load was measured using semi-quantitative microculture techniques to determine its predictive capability for progression to AIDS or survival among HIV-1 infected injecting drug users (IDU) and homosexual men (HM). The authors followed 296 IDU and 240 HM from February 1992 through September 1995 for: (i) death, (ii) AIDS, and (iii) AIDS or bacterial infection. At baseline, viral load was quantified using microculture techniques to determine infectious units per million peripheral blood mononuclear cells (IUPM). Data were analyzed using standard statistical methods for survival analysis. Of the 536 total participants, 106 died (20%), and 98 of the 481 AIDS-free participants developed AIDS (20%). The relative hazard of AIDS for a viral load of ≥100 IUPM, relative to a negative culture (0 IUPM), was 6.73 (95% CI: 2.23–20.3) after adjusting for risk group, initial CD4+ count, and other covariates. The adjusted relative hazard of death for a viral load of 100 IUPM vs. 0 IUPM was 2.57 (95% CI: 0.97–6.80). Viral load predicted time to death within the <200 cells/μl CD4+ stratum. The predictive value of viral load on HIV-1 progression did not vary by risk group. These data show that cell associated infectious HIV-1 viral load was significantly predictive of progression across risk groups for AIDS and death among those severely immune compromised.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of HIV disease: A review. J Infect Dis 1992; 165: 352-363.

    Google Scholar 

  2. Muñoz A, Vlahov D, Solomon L, et al. Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr 1992; 5: 694-700.

    Google Scholar 

  3. Fahey JL, Taylor JMG, Detels R, et al. The Prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. NEJM 1990; 332: 166-172.

    Google Scholar 

  4. Enger C, Grahan N, Peng Y, et al. Survival from early, intermediate, and late stages of HIV infection. JAMA 1996; 275: 1329-1334.

    Google Scholar 

  5. Mellors JW, Rinaldo CR, Gupto P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167-1170.

    Google Scholar 

  6. Katzenstein DA, Hammer JSM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996; 335: 1091-1098.

    Google Scholar 

  7. Mellors JW, Muñoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946-954.

    Google Scholar 

  8. Vlahov D, Graham NMH, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users — Plasma viral load and CD4+ cell count. JAMA 1998; 279(1): 35-40.

    Google Scholar 

  9. Lathey JL, Hughes MD, Fiscus SA, et al. Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm3 (ACTG 175). J Infect Dis 1998; 177: 617-624.

    Google Scholar 

  10. Fiscus SA, Hughes MD, Lathey JL, et al. Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. J Infect Dis 1998; 177: 625-633.

    Google Scholar 

  11. Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE study: A longitudinal study of HIV-1 infection in intravenous drug users: Description of methods J of Drug Issues 1991; 21: 759-776.

    Google Scholar 

  12. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR. The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126: 310-318.

    Google Scholar 

  13. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case for AIDS definition among adolescents and adults. MMWR CDC Surveill Summ 1992; 41: 1-19.

    Google Scholar 

  14. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1697-1703.

    Google Scholar 

  15. Selwyn PA, Feingold AR, Hartel D, et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 1988; 2: 267-272.

    Google Scholar 

  16. Caiaffa WT, Graham NMH, Vlahov D. Bacterial pneumonia in adult populations with HIV infection. Am J Epidemiol 1993; 138: 909-922.

    Google Scholar 

  17. Manoff SB, Vlahov D, Herskowitz A, et al. Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiol 1996; 7: 566-570.

    Google Scholar 

  18. Giorgi JV, Cheng H-L, Margolick JB, et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study (MACS) experience. Clin Immunol Immunopathol 1990; 55; 173-186.

    Google Scholar 

  19. Margolick JB, Scott ER, Chadwick KR, et al. Comparison of lymphocyte immunophenotypes obtained from two different data acquisition and analysis systems simultaneously on the same flow cytometer. Cytometry 1992; 13: 198-203.

    Google Scholar 

  20. Fiscus SA, DeGruttola V, Gupta P, et al. Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial. J Infect Dis 1995; 171: 305-311.

    Google Scholar 

  21. US Department of Health and Human Services. ACTG virology manual for HIV laboratories. Bethesda, MD: National Institute of Health, 1994: S1A-1-3; publication 94–3828.

    Google Scholar 

  22. Myers LE, McQuay LJ, Hollinger FB. Dilution assay statistics. J Clin Microbiol 1994; 32: 732-739.

    Google Scholar 

  23. Lee ET. Statistical methods for survival data analysis. 2nd ed. New York: Wiley and Sons, 1992.

    Google Scholar 

  24. Lyles CM, Vlahov D, Farzadegan H, et al. Comparison of two HIV-1 virologic measures in HIV risk groups. J Clin Microbiol (In press).

  25. Vella S, Giuliano M, Florida M, et al. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS 1995; 9: 51-56.

    Google Scholar 

  26. Spijkerman IJB, Langendam MW, Veugelers PJ, et al. Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion. Epidemiology 1996; 7: 571-577.

    Google Scholar 

  27. Melnick SL, Sherer R, Louis TA, et al. Survival and disease progression according to gender of patients with HIV infection. JAMA 1994; 272: 1915-1921.

    Google Scholar 

  28. Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. Am J Pub Health 1991; 81: 1285-1290.

    Google Scholar 

  29. Solomon L, Vlahov D, Astemborski J, Galai N, Graham NMH, Nelson KE. Factors associated with initiation of zidovudine in a cohort of injection drug users. J Drug Issues 1995; 25: 225-233.

    Google Scholar 

  30. Pezzotti P, Phillips, AN, Dorrucci M, et al. Category of exposure to HIV and age in progression to AIDS: Longitudinal study of 1199 people with known dates of seroconversion. Br Med J 1996; 313: 583-586.

    Google Scholar 

  31. Pezzotti P, Rezza G, Lazzarin A, et al. Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS. J Acquir Immune Defic Syndr 1992; 5: 745-747.

    Google Scholar 

  32. Palenicek J, Nelson KE, Vlahov D, Galai N, Cohn S, Saah A. Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men. Arch Intern Med 1993; 153: 1806-1812.

    Google Scholar 

  33. Hoover DR, Black C, Jacobsen LP, et al. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993; 138: 266-278.

    Google Scholar 

  34. Jacobson LP, Kirby AJ, Polk S, et al. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984–1991. Am J Epidemiol 1993; 138: 925-964.

    Google Scholar 

  35. Kifson AR, Darow WW, Hessol NA, et al. Kaposi's sarcoma in a cohort of homosexual and bisexual men, epidemiology and analysis for cofactors. Am J Epidemiol 1990; 131: 221-231.

    Google Scholar 

  36. Kaslow RA, Blackwelder WC, Ostrow DG, et al. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1 positive individuals. JAMA 1989; 261: 3424-3429.

    Google Scholar 

  37. Paxton WB, Coombs RW, McElrath MJ, Keefer MC, et al. Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with >400 CD4 lymphocytes: Implications for applying measurements to individual patients. J Infect Dis 1997; 175: 247-254.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Department of Epidemiology, The Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland, USA

    Cynthia M. Lyles, Jacquie Astemborski, David Vlahov, Alfred J. Saah & Homayoon Farzadegan

  2. Glaxo-Wellcome Inc., Research Triangle Park, North Carolina, USA

    Neil M. H. Graham

  3. The Department of Molecular Microbiology and Immunology, The, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland, USA

    Joseph B. Margolick

Authors
  1. Cynthia M. Lyles
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neil M. H. Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacquie Astemborski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Vlahov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joseph B. Margolick
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alfred J. Saah
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Homayoon Farzadegan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lyles, C.M., Graham, N.M.H., Astemborski, J. et al. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men. Eur J Epidemiol 15, 99–108 (1999). https://doi.org/10.1023/A:1007556327269

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007556327269

Search

Navigation